Anti-Ro Positivity in Systemic Lupus Erythematosus: Association with Clinical Phenotypes and Serological Profile
Open Access
- 22 July 2025
- journal article
- Published by World Scientific Pub Co Pte Ltd in Journal of Clinical Rheumatology and Immunology
- Vol. 25 (01) , 21-28
Abstract
Objective: To determine the association of anti-Ro antibody with the clinical features and serology in systemic lupus erythematosus (SLE) patients. Methods: This retrospective observational study enrolled 158 SLE patients at the Rheumatology Department, Fauji Foundation Hospital, from May 1 to October 31, 2023. Demographic and clinical data were collected. Patients were stratified by anti-Ro (positive vs. negative), concomitant anti-La (anti-Ro[ ]/anti-La[ ], anti-Ro[ ]/anti-La[ ], anti-Ro[ ]/anti-La[ ], and anti-Ro[ ]/anti-La[ ]), and anti-nuclear antibody (ANA) status (positive vs. negative). Mann-Whitney U and Chi-square tests were employed for comparisons, with statistical significance set at p<0.05. Results: The study population consisted mainly of females (98.7%), with a median age of 30 years. Anti-Ro[ ] patients (46.8%) exhibited higher discoid rash (16.2% vs. 6%, p [ ] 0.04), sicca symptoms (52.7% vs. 31%, p [ ] 0.005), and anemia (71.6% vs. 56%, p [ ] 0.04). No significant differences were observed in nephritis (29.7% vs. 34.5%, p [ ] 0.52) or neurological disease (9.5% vs. 11.9%, p [ ] 0.69) between the two groups. The anti-Ro[ ]/anti-La[ ] group had higher myositis (20.6%), sicca symptoms (55.9%), and fever (70.6%) compared to other groups. The ANA[ ]/anti-Ro[ ] group (48.6%) had significant association with sicca symptoms (50.7%) and fever (64.2%). Conclusion: Anti-Ro[ ] SLE in South Asians is associated with sicca symptoms, anemia, fever, and myositis—findings critical for tailored management. Co-positivity with anti-La amplifies risks, warranting vigilant monitoring.Keywords
This publication has 17 references indexed in Scilit:
- The implication of anti-Ro60 with or without anti-Ro52 antibody in patients with systemic lupus erythematosusRheumatology, 2024
- Interferons and systemic lupus erythematosus: Pathogenesis, clinical features, and treatments in interferon-driven diseaseModern Rheumatology, 2022
- Disease criteria of systemic lupus erythematosus (SLE); the potential role of non-criteria autoantibodiesJournal of Translational Autoimmunity, 2022
- Polyautoimmunity in systemic lupus erythematosus: secondary Sjogren syndromeZeitschrift für Rheumatologie, 2021
- The Asia-Pacific League of Associations for Rheumatology consensus statements on the management of systemic lupus erythematosusThe Lancet Rheumatology, 2021
- New insights into the role of antinuclear antibodies in systemic lupus erythematosusNature Reviews Rheumatology, 2020
- Primary Sjögren’s syndrome and the eyeSurvey of Ophthalmology, 2020
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus ErythematosusArthritis & Rheumatology, 2019
- Systemic lupus erythematosus: Diagnosis and clinical managementJournal of Autoimmunity, 2019
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusArthritis & Rheumatism, 2012